Concepedia

Keiko Esaki

KE

Statistics

Publications

11

Citations

1.3K

H-Index

11

Active since

1994

Affiliations

Chugai Pharma (United States)(Current)

Showa Pharmaceutical University

Osaka University of Pharmaceutical Sciences

Nara Medical University

Keiko Esaki is an author at Chugai Pharma (United States) specializing in immunology, monoclonal antibodies, and life sciences.

Publications per year

1994–2023

11

Publications

11

A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model

Takehisa Kitazawa, Tomoyuki Igawa, Zenjiro Sampei et al. · Nature Medicine · 2012 · 496 citations

, , +17

Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity

Zenjiro Sampei, Tomoyuki Igawa, Tetsuhiro Soeda et al. · PLoS ONE · 2013 · 325 citations · Full text

, , +17

Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens

Takehisa Kitazawa, Keiko Esaki, Tatsuhiko Tachibana et al. · Thrombosis and Haemostasis · 2017 · 201 citations · Full text

, , +16

Cynomolgus monkey model of interleukin‐31‐induced scratching depicts blockade of human interleukin‐31 receptor A by a humanized monoclonal antibody

Sohei Oyama, Hidetomo Kitamura, Taichi Kuramochi et al. · Experimental Dermatology · 2016 · 59 citations · Full text

, , +17

A bispecific antibody NXT007 exerts a hemostatic activity in hemophilia A monkeys enough to keep a nonhemophilic state

Yuri Teranishi-Ikawa, Tetsuhiro Soeda, Hikaru Koga et al. · Journal of Thrombosis and Haemostasis · 2023 · 44 citations · Full text

, , +17

1–5 of 11